US Tumor Marker Testing Market, 2019-2023: Supplier Shares by Test, and Market Segment Sales Forecasts

July 2019 | 40 pages | ID: UBC26DE3F0FEN
Venture Planning Group

Abstracts

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Contains 40 pages and 7 tables

Contents

BUSINESS ENVIRONMENT

1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
  a. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
11. Laboratory Regulations

MARKET STRUCTURE

1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Cancer Clinics
  c. Point of Care Testing
  d. Other Decentralized Testing Locations

MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES

List Of Tables

LIST OF TABLES

Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers